Insight into the association between phospholipase C-&#947;1 and the insulin receptor by Jang, Hyeung-Jin et al.
DOI: 10.2436/20.1501.02.18 Endocrinologia molecular
(Jaume Reventós, ed.)
Treballs de la SCB. Vol. 56 (2005) 183-194
INSIGHT INTO THE ASSOCIATION BETWEEN PHOSPHOLIPASE
C-γ1 AND THE INSULIN RECEPTOR
Hyeung-Jin Jang, Yong-Kook Kwon, Sutapa Kole and Michel Bernier
Diabetes Section, Laboratory of Clinical Investigation, National Institute on Aging,
National Institutes of Health, Baltimore.
Corresponding author: Michel Bernier. Diabetes Section, Laboratory of Clinical Investigation,
National Institute on Aging, National Institutes of Health, Baltimore. MD 21224, USA.
E-mail: Bernierm@mail.nih.gov.
RESUM
La identificació de senyals intermediaris que interaccionen directament amb el receptor d’in-
sulina (IR) és actualment objecte d’una intensa recerca, ja que sembla estar relacionada amb
l’acció de la insulina. Recentment, el nostre grup de recerca va establir l’associació induïble de
la fosfolipasa C (PLC)-γ1 amb l’IR i la seva implicació en la transducció de senyal mitjançada
per la insulina a través de l’activació de la ruta de la cinasa regulada per Ras. En aquest es-
tudi hem generat diversos mutants de la PCLγ1 per identificar i definir la funció dels residus
tiol PCLγ1 en el control de la interacció IR-PCLγ1 i determinar l’impacte que el redox cell. ular
té en el procés. Per aconseguir aquests objectius, hem utilitzat dos mètodes que demostren la
presència de sulfhidrils en la PCLγ1 sensibles a l’oxidació en cèll. ules CHO que expressen IR.
Diversos experiments de mutagènesi dirigida varen demostrar la modificació selectiva de les
cisteïnes 8 i 12 de PCLγ1 després de l’estimulació amb peròxid d’hidrogen i la inhibició d’oxida-
ses de membrana productores deROS. Aquestes dades suggereixen que la regió aminoterminal
de la PCLγ1 conté cisteïnes nucleofíliques particularment sensibles a la regulació redox i que
són necessàries per a la interacció eficient amb l’IR. La importància d’aquestes troballes s’ha
confirmat també en estudis sobre el paper regulador de la redox cell. ular en la transducció de
senyal de la insulina.Paraules clau: receptor d’insulina, fosfolipasaC, interaccions proteïna-proteïna, redox, trans-
ducció de senyal.
SUMMARY
An intense investigation is underway to identify the signaling intermediates that interact
directly with the insulin receptor (IR) as they appear to be associated with the transmission of
insulin action. We recently reported the inducible association of phospholipase C (PLC)γ1 with
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the IR and its involvement in the transduction of insulin-mediated signals through activation
of the Ras/extracellular-regulated kinase pathway. Akin to protein phosphorylation, redox reg-
ulation represents an important metabolic modulator of cellular functions. In this study, various
mutant forms of PCLγ1 were generated to identify putative key redox-sensitive cysteines that
provide sites for a number of post-translational modifications. Toward this aim, two methods
were used that demonstrate the presence of oxidation-sensitive cysteine residues in PCLγ1. Us-
ing site-directed mutagenesis experiments we found that two cysteines in PCLγ1 (Cys-8 and
Cys-12) were modified with hydrogen peroxide and protected against a host of reactive oxy-
gen species through pharmacological inhibition of cellular membrane oxidases. The data sug-
gest that the amino-terminal region of PCLγ1 contains reactive cysteine-SH groups that are ex-
quisitely sensitive to redox regulation and which are associated with efficient interaction with
the IR. The importance of these findings is already asserting themselves in studies reporting
the regulatory role of cellular redox in insulin signal transduction.Keywords: insulin receptor, phospholipase Cγ1, protein-protein interaction, oxidative stress,
signal transduction.
INTRODUCTION
The physiological effects of insulin are me-
diated by activation of the intrinsic tyrosine
kinase function of the insulin receptor (IR)
and its association with a number of scaf-
fold molecules (e.g., IRS-1, Gab-1) harboring
distinct recognition domains for the bind-
ing of signaling-competent effector proteins
(Saltiel and Pessin, 2002). The insulin receptor
is a heterotetrameric glycoprotein consisting
of two α-β dimers linked by disulfide bonds
(Garant et al., 1999). We used a novel proce-
dure to study the interaction between IR and
endogenous molecules in cells by taking ad-
vantage of the fact that the homobifunctional
crosslinking reagent 1,6-bismaleimidohexane
(BMH) selectively reacts with nucleophilic
cysteine residues to form an irreversible link
between two interacting proteins (Garant et
al., 2000). Immunoprecipitation-based tech-
nique coupled with mass spectrometry analy-
sis allowed us to establish that insulin pro-
moted the formation of a covalent complex
between the IR β-subunit and phospholipase
(PLC)γ1 upon addition of BMH to chinese
hamster ovary (CHO) cells stably expressing
the human IR (Kwon et al., 2003) (see figure
1A, B). Western blot analysis independently
confirmed the recruitment of PCLγ1 to the IR
following insulin stimulation of a number of
cell types. Of significance, the amino-terminal
region of PCLγ1, which consists of a pleck-
strin homology (PH) domain and a series of
EF-hands, has been proposed to contribute to
the interaction between PCLγ1 and the ac-
tivated IR (Kwon et al., 2003; Bernier et al.,
2004).
PCLγ1 plays an important role in the
intracellular transduction of receptor and
nonreceptor tyrosine kinases. It is widely
distributed and exerts essential function in
mammalian growth and development as ev-
idenced by the fact that mice deficient in
PCLγ1 are embryonic lethal (Ji et al. 1997).
PCLγ1 is a member of the family of phos-
phoinositide–specific PLCs that convert phos-
phatidylinositol 4,5-bisphosphate (PI4,5P2) to
two second messengers, inositol 1,4,5-trispho-
sphate (IP3) and 1,2-diacylglycerol (DAG),
upon cell activation (Rhee, 2001). IP3 mo-
bilizes Ca2+ from intracellular stores, while
DAG is responsible for the activation of a sub-
set of protein kinase C isoforms (e.g., α, β, τ,
). Activation of a chimeric receptor contain-
ing the juxtamembrane and tyrosine kinase
domains of the IR led to PCLγ1 activation
and concomittant increase in calcium mobi-
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Figure 1. A) Schematic representation of the covalent recruitment of PCLγ1 to the intra-
cellular domain of the IR β-subunit in insulin-stimulated cells in the presence of BMH, a
homobifunctional thiol-specific crosslinking agent. B) Immunoblot analysis in support of this
process. pY783, mAb antibody specific for tyrosine phosphorylated PCLγ1. C) Identification
of putative PCLγ1 nucleophilic cysteines using the thiol-modifying agent MBB. * denotes ac-
cessible cysteine(s) with low pKa at physiological pH. Panels A and B were reproduced from
Bernier et al. (2004).
lization (Telting et al., 1999). PCLγ1-mediated
PI4,5P2 hydrolysis in anti-IR immunoprecip-
itates has been found in insulin-stimulated
3T3-L1 adipocytes (Eichhorn et al., 2001).
PCLγ1 participates in insulin-stimulated glu-
cose uptake in adipocytes through activation
of DAG-sensitive PKCζ (Lorenzo et al., 2002),
whereas microinjection of neutralizing anti-
bodies to PCLγ1 interferes with insulin’s abil-
ity to induce DNA synthesis in IR-express-
ing Rat-1 fibroblasts (Eichhorn et al., 2002).
Finally, knockdown of PCLγ1 expression by
RNA interference significantly reduces acti-
vation of extracellular-regulated kinase (ERK)
pathway, but not that of Akt, in response to
insulin, whereas reconstitution of PCLγ1 in
PCLγ1–/– mouse embryonic fibroblasts elicits
a marked increase in insulin-stimulated ERK
activation (Kwon et al., 2003). These and other
data provide clear indication that increased
PCLγ1 activity could modulate the metabolic
and mitogenic effects of insulin.
The juxtamembrane region of the human
IR cytoplasmic domain contains a cysteine
residue that exhibits low pKa at physiolog-
ical pH (Bernier et al., 1995; Bernier et al.,
2004), which makes it a chemical hot spot for
a number of biochemical interactions. Indeed,
the selective sensitivity of Cys-981 to thiol-
modifying agents, such as maleimidobutyryl
biocytin (MBB), was used to our advantage
in tagging human IR in intact cells (Garant
et al., 2000). However, no studies have been
performed to test the presence of reactive cys-
teine residue(s) in PCLγ1, which could ac-
count for its ability to covalently bind the IR
upon BMH treatment. On the basis of this,
we set out experiments to identify oxidation-
sensitive cysteine-SH groups in PCLγ1 and
assess their role in the control of IR-PCLγ1
covalent interaction in the presence of BMH.
While the mechanism of IR-PCLγ1 interaction
remains to be fully elucidated, analysis of the
cysteine residues in PCLγ1 that are potentially
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Figure 2. (facing page) PCLγ1 contains reactive thiols. A)
Schematic representation of variousHA-tagged PCLγ1 constructs
generated in this study. B) Thiol-specific biotinylation of wild-
type and mutant forms of PCLγ1 in CHO-IR cells. Serum-starved
cells expressing wild-type (WT), ∆216C, ∆304N, or C8A/C12A
double point mutant form of PCLγ1 were semipermeabilized with
digitonin in the presence of 100 µM MBB for 10 min at 6 °C.
Anti-HA immunoprecipitates from cell lysates were resolved by
SDS-PAGE and blotted with HRP-conjugated streptavidin (SA-
HRP) to detect thiol-biotinylation signals. The membrane was
then reprobed with HA antibody (lower panel). C) Serum-starved
CHO-IR cells expressing empty vector (–) or HA304N (+) were
subjected to MBB-induced thiol biotinylation as indicated above.
Anti-PCLγ1 immunoprecipitates were prepared and analyzed by
Western blot using SA-HRP and anti-HA antibody. D-E) CHO-
IR cells ectopically expressing empty vector (pcDNA), the wild-
type HA304N or various Cys->Ala mutant forms of HA-304A
(C8C12AA, C106A, C247A) were incubated in the absence (–)
or the presence (+) of 100 µM BMH for 10 min at 6 °C before
quenching the reaction with L-cysteine. Anti-HA immunopre-
cipitates (D, lower panel) or total cell lysates were analyzed by
Western blot with the indicated primary antibodies.
susceptible to redox regulation may provide
new insight into PCLγ1 function.
METHODS
Plasmid constructs. C-and N-terminal frag-
ments and a double point-mutation (C8A/
C12A) of the rat PCLγ1 (NM_013187) were
generated using plasmid pRK5/HA-PCLγ1
(kindly provided by Graham Carpenter Nash-
ville, TN, USA). The generation of HA
(hemagglutinin) epitope-tagged 304N (from
a.a. 1-304 of PCLγ1, which contains PH do-
main and EF-hands) involved a PCR-based
site-directed mutagenesis approach to intro-
duce HindIII restriction site between EF-
hands and catalytic domain “X” of PCLγ1.
An HindIII/HindIII fragment (2961 bp long)
was excised. To generate PCLγ1 ∆216C mu-
tant (deletion of a.a. 1075-1291, which contains
C2 domain), HindIII restriction site was in-
troduced by mutating the region (3309AAGC-
CTTTG3317) to AAGCTTTTG. An HindIII/
HindIII fragment (660 bp long) was excised.
The construction of PCLγ1∆304N mutant
was carried out as followed: Two EcoRI re-
striction sites were introduced by mutating
the region (100ΓCGTCGG108) and (900AC-
CGGCTTC908) to GGAATTCGG and ACC-
GAATTC, respectively, while deleting EcoRI
site present in pRK5 vector’s multicloning
site. An EcoRI/EcoRI fragment encompassing
304N was excised. The linearized pRK5/HA-
tagged plasmids were then self-ligated. The
cysteine 8 and 12 to alanine mutation in
PCLγ1 (C8A/C12A) was introduced by re-
placing codon TGC with GCC. Similarly, sev-
eral point-mutations of HA-304N (termed
C8C12AA, C26A, C106A, and C247A) were
constructed using the QuickChange site-di-
rected mutagenesis kit (Stratagene). All of the
mutations were verified by DNA sequence
analysis.
Cell culture. CHO cells expressing the hu-
man IR (CHO-IR) cells were maintained
and grown to near confluence in Ham’s F-
12 medium supplemented with 10% FBS,
glutamine and penicillin/streptomycin. Cells
were then maintained in medium without
serum (SFM) for 4 h, after which 100 nM
insulin was added for 5 min. In some in-
stances, cells were treated for 30 min with
either vehicle (dimethylsulfoxide, DMSO),
diphenyleneiodonium chloride (DPI; Alexis
Corp., San Diego, CA), hydrogen peroxide
(H2O2; Fisher), pyrrolidinedithiocarbamate
(PDTC; Calbiochem, La Jolla,CA), bpV(phen)
(Calbiochem) or thioctic acid (oxidized form)
(Sigma-Aldrich, St-Louis,MO) prior to the ad-
dition of insulin.
Transient transfection assays. CHO-IR cells
were transfected by the Lipofectamine2000
method (Invitrogen). Empty expression vec-
tor and expression plasmids encoding wild-
type or mutant forms of PCLγ1 were mixed
with the transfection reagent and directly
added into the culture plates at a ratio of 2-
4 µg of each plasmid/60-mm dish. Twenty
hours later, cells were serum-starved for 3 h
and then subjected to treatments as described
below.
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Thiol-specific biotinylation and BMH-mediated
chemical crosslinking of PCLγ1 in cells. Serum-
starved cells were washed twice in phosphate-
buffered saline (PBS), and then incubated
in Krebs Ringer Phosphate (KRP) buffer for
5-30 min at 37 oC before their transfer to
thermoregulated aluminium cooling plates
set at 6 oC. The thiol-biotinylation reaction
was initiated by the simultaneous addition
of 20 µg/ml digitonin and 100 µM MBB
(Calbiochem) for 10 min, with subsequent
addition of 4 mM L-cysteine to quench the
reaction. Detection of biotinylated protein
sulfhydryls was carried out by Western blot
using HRP-conjugated streptavidin (Vector
Lab, Burlingame, CA). The crosslinking reac-
tion followed the procedure of Garant et al.,
(2000). After a 5-min stimulation with insulin
(100 nM) in KRP buffer, cells were transferred
to 6 oC and then the crosslinking reaction
was initiated by the addition of 100 µM BMH
(Pierce Chemical Corp., Rockford, IL) or vehi-
cle (DMSO) and quenched 10 min later with
4 mM L-cysteine.
Immunoprecipitation and Western blot analy-
sis. Cell lysis was performed using estab-
lished procedures (Kwon et al., 2003). Follow-
ing appropriate treatment of the cells, cells
were washed once with PBS and then lysed
in radioimmune precipitation buffer contain-
ing 20 mM Tris-HCl, pH 7.5, 137 mM NaCl,
0.1% SDS, 0.5% deoxycholate, 1% Triton X-
100, 0.02% NaN3, 100 mM NaF, 1 mM or-
thovanadate, and protease inhibitor cocktail
(Calbiochem). The clarified lysates were iso-
lated from homogenates by centrifugation at
4 °C. An aliquot was suspended in 62.5 mM
Tris-HCl (pH 6.8), 2% SDS, 10% glycerol,
5% β-mercaptoethanol and heated at 70 °C
for 10 min. A second aliquot of the clari-
fied lysates was incubated with mAb anti-
PCLγ1 (Chemicon International; N-terminal
epitope) or mAb anti-IR (clone 29B4; Cal-
biochem) for 16 h at 4 °C. The samples
were subjected to SDS-polyacrylamide gel
electrophoresis under reducing conditions,
transferred onto PVDF membrane and then
blots were incubated with primary antibod-
ies in blocking buffer (mAb anti-HA an-
tibody (Covance); rabbit anti-IR α-subunit
and anti-IκBα (Santa Cruz Biotechnology);
rabbit anti-phosphoPCLγ1 (pY783) antibody
(BioSource International); antiphosphotyro-
sine (clone RC20)-linked to HRP and rabbit
anti-IR β-subunit (Transduction Lab)). Bound
antibody was detected using enhanced chemi-
luminescence according to established proto-
cols.
Assay of intracellular H2O2. Serum-starved
CHO-IR cells were incubated with 100 µM
H2O2 or 10 µM DPI for 30 min before the
addition of 100 nM insulin. Five min later,
4 µM dichlorohydrofluorescein (CM-H2DCF-
DA; Molecular Probes, Eugene, OR) was
added in the dark for 10 min at room temper-
ature. Fluorescence of the indicator dye was
visualized using a Zeiss LSM-410 inverted
confocal microscope at an excitation wave-
length of 488 nm and emission at 515/540 nm.
RESULTS
PCLγ1 contains reactive thiols. MBB is a
biotin-containing, thiol-specific reagent that
reacts readily with proteins containing cys-
teine residues. When combined with strep-
tavidin-conjugated HRP, this approach al-
lows the detection of redox-sensitive cys-
teines. MBB was used successfully to identify
Cys981 of the human IR as a nucleophilic thiol
(Bernier et al., 1995).
Following transient expression of wild-type
and mutant forms of HA-tagged PCLγ1 in
CHO-IR cells (see figure 2A), MBB- medi-
ated thiol-biotinylation reaction was carried
out and anti-HA immunoprecipitates were
evaluated for the content of reactive cysteines
by Western blotting (see figure 2B). A sig-
nificant incorporation of biotin was observed
in wild-type PCLγ1 after administration of
MBB to semi-permeabilized cells, which sup-
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ports the notion that PCLγ1 contains reactive
cysteine residues at physiological pH. Simi-
lar to wild-type PCLγ1, ∆304N and ∆216C
PCLγ1 mutants showed strong reactivity to
MBB, whereas the level of thiol-biotinylated
C8A/C12A PCLγ1 mutant was markedly
lower (see figure 2B, upper panel). Reprob-
ing the membrane with anti-HA showed the
relative expression level of each PCLγ1 con-
struct (see figure 2B, lower panel). To further
establish the presence of reactive cysteines in
the N-terminal region of PCLγ1, HA-304N
(which contains the PH-EF domain) was ex-
pressed in CHO-IR cells and subjected to
thiol-biotinylation (see figure 2C). The results
showed the conjugation of HA-304N with bi-
otin. Moreover, the construct exhibited BMH-
induced chemical crosslinking, as evidenced
by the reduced signal at 43 kDa in HA im-
munoprecipitates (see figure 2D). As shown
in see figure 2A, the N-terminal region of
PCLγ1 contains 5 cysteines, some of which
may be subject to oxidative modification. Var-
ious Cys to Ala point-mutants of HA-304N
were generated and analyzed for their re-
sponse to BMH-induced crosslinking in intact
CHO-IR cells (see figure 2E, upper panel).
The results clearly showed a sharp reduction
in the recovery of monomeric forms of WT,
C106A and C247A mutants following BMH
treatment, while having no detectable effect
on C8C12AA. C26A expression was very low
and thus could not provide reliable informa-
tion (data not shown). Reprobing the mem-
brane with anti-IκBα antibody indicated that
BMH was effective at promoting thiol modi-
fication of IκBα protein in each cell line (see
figure 2E, lower panel). Taken together, our
data revealed that PCLγ1 possesses reactive
cysteine residues at position 8 and 12.
Modulation of PCLγ1 thiol reactivity in in-
tact cells. Several enzymes that regulate down-
stream components in the insulin signaling
cascade are potential targets of redox modi-
fications that take place in cells exposed to a
host of reactive oxygen and nitrogen species
(Finkel, 2003). To measure the generation of
intracellular H2O2, cells are loaded with the
redox indicator dye based on dichlorohydro-
fluorescein (CM-H2DCF-DA) that is trapped
intracellularly after cleavage by cellular es-
terases. Following stimulation of CHO-IR
cells with 100 nM insulin, an oxidant signal
was detected by DCF fluorescence, which
peaked at 5 min (see figure 3A, panel b), and
began to dissipate by 10 min (not shown). Oth-
ers have reported that the oxidant generated
by insulin was H2O2, as preincubation of the
cells with catalase attenuated the fluorescent
signal (Mahadev et al., 2001). Exogenous addi-
tion of H2O2 markedly increased DCF signal
(see figure 3A, panel c), whereas incubation of
the cells with diphenyleneiodonium (DPI), an
inhibitor of cellular NADPH oxidase activity,
blocked the production of H2O2 in response
to insulin (see figure 3A, panel d). We then
investigated the effect of DPI and H2O2 on
PCLγ1 thiol reactivity in CHO-IR cells. When
cells were treated with DPI, the incorpora-
tion of MBB in wild-type PCLγ1 increased
3-fold while having no detectable effect on the
C8A/C12A mutant (see figure 3B). Addition
of exogenous H2O2 caused a 50% and full re-
duction in thiol biotinylation of the wild-type
PCLγ1 and C8A/C12A mutant, respectively.
The data suggest that PCLγ1 contains a dis-
crete subset of cysteines that are likely to be
involved in the response of PLCγ1 to redox
modification. The absence of cysteines 8 and
12 in C8A/C12A mutant confers refractive-
ness to DPI action.
Insulin facilitates the recruitment of PCLγ1
to the activated IR, enabling both proteins to
be covalently linked using BMH, a selective
homobifunctional thiol-specific crosslinker
(Kwon et al., 2003). To test whether alteration
in cellular redox could affect this process,
CHO-IR cells were preincubated with DPI
or H2O2 followed by the addition of in-
sulin and subsequent treatment with BMH
(see figure 3C). A dose-dependent enhance-
ment in IR-PCLγ1 covalent association was
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achieved with DPI with concomittant reduc-
tion in unconjugated IR β-subunit (see fig-
ure 3C, left panel). Conversely, H2O2, which
increases cellular thiol oxidation (see figure
3B), dose-dependently reduced covalent bind-
ing of PCLγ1 to the IR (see figure 3C, right
panel) while promoting the recovery of tyro-
sine phosphorylated IR β-subunit and PCLγ1
(see figure 3D).
BpV(phen) is a stable peroxovanadium
compound with insulinomimetic properties
by virtue of its ability to activate the IR kinase
and subsequent stimulation of downstream
signaling (Bevan et al., 1995). Previous studies
indicated that bpV(phen) induces the produc-
tion of intracellular superoxide anion through
activation of NADPH oxidase at the plasma
membrane (Yamaguchi et al., 1995), which
leads to transient cytosolic acidification (Bian-
chini et al., 1994). We next ascertain the effect
of bpV(phen) on BMH-dependent IR-PCLγ1
crosslinking. When stimulated with insulin
and challenged with 20 µM bpV(phen), CHO-
IR cells exhibited a marked attenuation in
IR-PCLγ1 complex formation (see figure 3E,
lane 2 vs. 1). Because antioxidants can offer
cellular defense against oxidative stress (Roy
et al., 1997), we tested the effect of three struc-
turally unrelated antioxidants on the cellular
response to bpV(phen). While thioctic acid (α-
lipoic acid) and the metal chelator PDTC were
mostly ineffective at counteracting bpV(phen)
signaling, pretreatment with DPI for 30 min
led to a prominent retention of the IR-PCLγ1
complex despite the presence of bpV(phen)
(see figures 3E and 3F). The data support the
model whereby plasma membrane NADPH
oxidase activity plays a key role in the regu-
lation of protein-protein interaction of redox-
sensitive signaling molecules, such as PCLγ1
and the IR.
DISCUSSION
In our previous work, we have shown that
Figure 3. (facing page) The effect of redox regulation on
PCLγ1 thiol reactivity and its BMH-mediated covalent associa-
tion with the IR. A) Production of H2O2 in CHO-IR cells in re-
sponse to various stimuli. Serum-starved CHO-IR cells were left
untreated (a) or treated for 30 min with 100 nM insulin (b), or 5 µM
DPI for 20 min prior to the addition of insulin (d). Cells were then
incubated with 4 µMDCF for an additional 20 min in the dark. As
control, exogenous H2O2 (100 µM, panel c) was added for 30 min
prior to the addition of DCF. Intracellular H2O2 production was
detected by fluorescence of the indicator dye. B) Serum-starved
CHO-IR cells expressing the wild-type PCLγ1 or C8A/C12A mu-
tant were incubated with vehicle, 5 µM DPI or 100 µM H2O2
for 30 min followed by thiol-specific biotinylation reaction with
MBB. Anti-PLCγ1 immunoprecipitations were prepared, and the
biotin incorporation in PCLγ1 quantitated by densitometry using
ImageQuant software (Molecular Dynamics, Sunnyvale, CA). A
value of 1.0 was assigned to the biotin/PCLγ1 ratio of untreated
cells expressing the wild-type PCLγ1. Bars are averages ± range
of two independent experiments. C, D) Thiol-specific crosslink-
ing of PCLγ1 with IR in intact CHO-IR cells. E) Following a 30-
min preincubation in the presence of vehicle, DPI (5 µM), PDTC
(25 µM) or thioctic acid (TA; 100 µM), CHO-IR cells were treated
without (–) or with (+) 20 µM bpV(phen) for 1 h after which in-
sulin (100 nM) was added for 10 min. Cells were then subjected
to BMH crosslinking as described under Methods. Western blot
analysis of cell lysates was performed with anti-IR β-subunit (up-
per panel) followed by immunodetection of IR α-subunit (lower
panel). F) Similar experiment as in E was performed, whereby
various doses of DPI (0.1, 0.5, 1 and 5 µM), PDTC (5, 25, 100
µM) or TA (25, 100, 250 µM) were used. Results are expressed
as the means ± SEM of three experiments, where the residual
crosslinking signal elicited by bpV(phen) alone was substracted
from the signal obtained following preincubation with antioxi-
dants. ** denotes the BMH-induced covalent complex betweeen
the IR β-subunit and PCLγ1. +, ++ P < 0.05 and < 0.01, respec-
tively, compared with bpV(phen) alone.
PCLγ1 covalently binds to the activated IR
upon addition of BMH to insulin-stimulated
CHO-IR cells (Kwon et al., 2003). Deletion of
the juxtamembrane NPEY motif or truncation
of the carboxyl 43 amino acids of the IR did
not inhibit this process (Bernier et al., 2004),
suggesting that the association of PCLγ1 with
the IR occurs at a region/motif that differs
from that required by the well-known effec-
tors of insulin action (Kharitonenkov et al.,
1995; Sawka-Vervelle et al., 1996; O’Neill et
al., 1996; Kasus-Jacobi et al., 1998). It is gen-
erally accepted that intracellular redox plays
an important role in the modulation of insulin
action. The results of our study document an
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active role of a discrete population of Cys-SH
moieties in mediating IR-PCLγ1 covalent as-
sociation in response to BMH, in particular
those present in the NH2-terminus of PCLγ1.
We approached their characterization by ec-
topically expressing wild-type, truncated ver-
sions and point-mutant forms of PCLγ1 pro-
teins in CHO-IR cells.
Ectopic expression of PCLγ1 N-terminal
fragment, 304N (which contains PH domain
and EF-hands), was described as having great
potency in interfering with endogenous IR-
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PCLγ1 interaction (Kwon et al., 2003). Our
present data show that 304N contains cys-
teines that are reactive to cell redox modifiers.
Substitution of PCLγ1 at Cys-8 and -12, but
not those present in the PH-EF-hands, abro-
gated responsiveness to BMH while reduc-
ing thiol-alkylation with MBB by only 60%,
which could indicate the presence of addi-
tional reactive Cys-SH moieties at a site (or
sites) distant from the N-terminus of PCLγ1.
By extension, we propose that these distant
Cys residues do not play a role in BMH-
mediated covalent binding of PCLγ1 to the
IR, which relies instead on the close prox-
imity of the N-terminus PCLγ1 thiol(s) with
Cys981 of the human IR. We have recently ob-
served that cell stimulation with insulin led
to the detection of both the IR and activated,
tyrosine-phosphorylated form of PCLγ1 in
subdomains of the plasma membrane known
as lipid rafts (Kwon et al., in preparation).
Rafts are enriched in actin filaments and have
been proposed to serve several important
functions, including the preassembly of sig-
naling proteins onto a cytoskeletal scaffold
(Whitehead et al., 2000). Interestingly, reac-
tive cysteine moieties are frequent sites for
the posttranslational addition of lipids to in-
tegral membrane and membrane-associated
proteins. These acylation reactions have been
shown to be required for optimal targeting
and proper function of several families of sig-
naling molecules at the plasma membrane
(Resh, 2004). Our present data are the first to
document the presence of oxidation-sensitive
nucleophilic thiols in PCLγ1; whether lipid
modification of PCLγ1 is required for its tar-
geting to rafts microdomains and tyrosine
phosphorylation following cell activation by
insulin is unclear. Such thioester bond may
be transitory and have transient regulatory ef-
fects on the protein function. Experiments are
currently underway to fully characterize the
importance of a cell’s redox system in con-
trolling the targeting and cellular function of
PCLγ1.
We found that the inhibition of cellular
NADPH oxidases by DPI was the most ef-
fective approach against bpV(phen)-mediated
decrease in BMH-dependant IR-PCLγ1 cross-
linking. It is thought that bpV(phen) can in-
duce superoxide anion production as a result
of translocation and phosphorylation of the
47-kDa protein component of the NADPH
oxidase at the plasma membrane where the
catalytic flavocytochrome b resides (Yaname
et al., 1999). Herein, the increase in intracellu-
lar H2O2 production with bpV(phen) inCHO-
IR cells (data not shown) is likely to pro-
mote oxidative thiol modification on either
the IR, PCLγ1 or both proteins, thus impact-
ing on their reactivity toward BMH. Com-
ponents of the NADPH oxidase are known
to be localized on the cytoplasmic surface
of the plasma membrane through associa-
tion wtih the actin cytoskeleton (Woodman
et al., 1991; el Benna et al., 1994; Buul et al.,
2005). Similar to the components of this ox-
idase, PCLγ1 binds to elements of the cy-
toskeleton that directly appose the plasma
membrane of the cell (Chou et al., 2002).
These results support the view that insulin-
mediated PCLγ1 signal transduction involves
an oxidation-sensitive pathway through ac-
tivation of NADPH oxidase at the plasma
membrane.
Changes in cellular redox are known to oc-
cur with aging, diabetes and other metabolic
conditions (Browlee, 2001). The consequences
of oxidative damage include altered cell sig-
naling, proliferation and apoptosis. We be-
lieve that PCLγ1 is target of such oxidative
attack due to the presence of reactive cysteine
residues in its N-terminal domain. PCLγ1
binding to the IR has been associated with
upregulation of the Ras/ERK pathway in re-
sponse to acute insulin stimulation (Kwon et
al., 2003). Better knowledge of the implica-
tions of redox alterations will open new op-
portunities into the understanding of PCLγ1
signaling and provide a new insight into the
ways this enzyme exerts the pleiotropic ac-
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tions of insulin in normal and pathophysio-
logical states.
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